PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| empenthrin (ISO); 1-ethynyl-2-methylpent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | 687-638-9 | 918500-11-5 | - | - | - | - | - | 1 | - | - | - | Details |
| emamectin benzoate (ISO); (4’’R)-4’’-deoxy-4’’-(methylamino)avermectin B1 benzoate | 605-015-1 | 155569-91-8 | - | - | - | - | - | 1 | - | - | - | Details |
| DPX-Q8U80 | 832-861-0 | 1254304-22-7 | - | - | - | - | - | 1 | - | - | - | Details |
| Dodine | 219-459-5 | 2439-10-3 | - | - | - | - | 1 | 1 | - | - | - | Details |
| Dodemorph acetate | 250-778-2 | 31717-87-0 | - | - | - | - | - | 1 | - | - | - | Details |
| Dodemorph | 216-474-9 | 1593-77-7 | - | - | - | - | - | 1 | - | - | - | Details |
| Dodecyl methacrylate | 205-570-6 | 142-90-5 | - | - | 3 | - | 1 | 1 | - | - | - | Details |
| Dodecyl acetate | 203-995-1 | 112-66-3 | - | - | - | - | - | 1 | - | - | - | Details |
| Divanadium pentaoxide | 215-239-8 | 1314-62-1 | - | - | 2 | - | 1 | 1 | - | - | - | Details |
| diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea | 206-354-4 | 330-54-1 | 1 | - | 1 | 2 | - | 1 | - | - | - | Details |